Latest BRAIDWELL LP Stock Portfolio
BRAIDWELL LP Performance:
2024 Q3: 0.24%YTD: -1.28%2023: -6.08%
Performance for 2024 Q3 is 0.24%, and YTD is -1.28%, and 2023 is -6.08%.
About BRAIDWELL LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, BRAIDWELL LP reported an equity portfolio of $3.5 Billions as of 30 Sep, 2024.
The top stock holdings of BRAIDWELL LP are , XENE, NBIX. The fund has invested 3.4% of it's portfolio in CG ONCOLOGY INC and 3% of portfolio in XENON PHARMACEUTICALS INC.
The fund managers got completely rid off THERMO FISHER SCIENTIFIC INC (TMO), TRANSMEDICS GROUP INC (TMDX) and IMMUNOCORE HLDGS PLC (IMCR) stocks. They significantly reduced their stock positions in LEXICON PHARMACEUTICALS INC (LXRX), IOVANCE BIOTHERAPEUTICS INC (IOVA) and ELEVATION ONCOLOGY INC (ELEV). BRAIDWELL LP opened new stock positions in EDGEWISE THERAPEUTICS INC (EWTX), BICARA THERAPEUTICS INC and MADRIGAL PHARMACEUTICALS INC (MDGL). The fund showed a lot of confidence in some stocks as they added substantially to CULLINAN THERAPEUTICS INC (CGEM), APELLIS PHARMACEUTICALS INC (APLS) and SAREPTA THERAPEUTICS INC (SRPT).
The top stock holdings of BRAIDWELL LP are , XENE, NBIX. The fund has invested 3.4% of it's portfolio in CG ONCOLOGY INC and 3% of portfolio in XENON PHARMACEUTICALS INC.
The fund managers got completely rid off THERMO FISHER SCIENTIFIC INC (TMO), TRANSMEDICS GROUP INC (TMDX) and IMMUNOCORE HLDGS PLC (IMCR) stocks. They significantly reduced their stock positions in LEXICON PHARMACEUTICALS INC (LXRX), IOVANCE BIOTHERAPEUTICS INC (IOVA) and ELEVATION ONCOLOGY INC (ELEV). BRAIDWELL LP opened new stock positions in EDGEWISE THERAPEUTICS INC (EWTX), BICARA THERAPEUTICS INC and MADRIGAL PHARMACEUTICALS INC (MDGL). The fund showed a lot of confidence in some stocks as they added substantially to CULLINAN THERAPEUTICS INC (CGEM), APELLIS PHARMACEUTICALS INC (APLS) and SAREPTA THERAPEUTICS INC (SRPT).
BRAIDWELL LP Annual Return Estimates Vs S&P 500
Our best estimate is that BRAIDWELL LP made a return of 0.24% in the last quarter. In trailing 12 months, it's portfolio return was 4.78%.
New Buys
| Ticker | $ Bought |
|---|---|
| edgewise therapeutics inc | 52,267,300 |
| bicara therapeutics inc | 42,219,100 |
| madrigal pharmaceuticals inc | 39,009,900 |
| dexcom inc | 29,570,400 |
| biontech se | 29,425,300 |
| amphastar pharmaceuticals in | 19,521,200 |
| immatics n.v | 18,798,700 |
| boston scientific corp | 15,855,000 |
New stocks bought by BRAIDWELL LP
Additions
Additions to existing portfolio by BRAIDWELL LP
Reductions
| Ticker | % Reduced |
|---|---|
| lexicon pharmaceuticals inc | -90.34 |
| iovance biotherapeutics inc | -85.14 |
| elevation oncology inc | -80.89 |
| exact sciences corp | -74.93 |
| vaxcyte inc | -63.19 |
| lexeo therapeutics inc | -47.28 |
| argenx se | -42.06 |
| glaukos corp | -37.25 |
BRAIDWELL LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| sarepta therapeutics inc | -55,512,100 |
| conmed corp | -4,477,570 |
| akero therapeutics inc | -25,440,000 |
| immunocore hldgs plc | -27,019,400 |
| outset med inc | -2,673,920 |
| longboard pharmaceuticals in | -5,566,180 |
| transmedics group inc | -28,611,800 |
| livanova plc | -9,533,200 |
BRAIDWELL LP got rid off the above stocks
Sector Distribution
BRAIDWELL LP has about 74.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 74.2 |
| Others | 25.6 |
Market Cap. Distribution
BRAIDWELL LP has about 15.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 31.8 |
| SMALL-CAP | 26.5 |
| UNALLOCATED | 25.6 |
| LARGE-CAP | 15.1 |
| MICRO-CAP | 1.1 |
Stocks belong to which Index?
About 44.5% of the stocks held by BRAIDWELL LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 55.5 |
| RUSSELL 2000 | 36.8 |
| S&P 500 | 7.7 |
BRAIDWELL LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BRAIDWELL LP
BRAIDWELL LP has 65 stocks in it's portfolio. About 25.4% of the portfolio is in top 10 stocks. APLS proved to be the most loss making stock for the portfolio. INSP was the most profitable stock for BRAIDWELL LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AGLE | spyre therapeutics inc | 1.82 | 2,189,840 | 64,403,100 | reduced | -12.91 | ||
| AKRO | akero therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALEC | alector inc | 0.28 | 2,158,240 | 10,057,400 | reduced | -9.34 | ||
| ALGN | align technology inc | 2.25 | 311,679 | 79,266,200 | added | 13.25 | ||
| AMPH | amphastar pharmaceuticals in | 0.55 | 18,400,000 | 19,521,200 | new | |||
| APLS | apellis pharmaceuticals inc | 2.56 | 3,125,180 | 90,130,300 | added | 410 | ||
| ARVN | arvinas inc | 0.90 | 1,284,470 | 31,636,500 | added | 148 | ||
| ATEC | alphatec hldgs inc | 1.49 | 58,217,000 | 52,510,800 | unchanged | 0.00 | ||
| ATEC | alphatec hldgs inc | 0.64 | 4,041,060 | 22,468,300 | added | 84.11 | ||
| BBIO | bridgebio pharma inc | 4.13 | 140,838,000 | 145,613,000 | unchanged | 0.00 | ||
| BBIO | bridgebio pharma inc | 1.28 | 53,594,000 | 45,019,000 | reduced | -18.29 | ||
| BBIO | bridgebio pharma inc | 0.22 | 298,400 | 7,597,260 | reduced | -13.65 | ||
| BSX | boston scientific corp | 0.45 | 189,200 | 15,855,000 | new | |||
| CELC | celcuity inc | 0.37 | 884,306 | 13,185,000 | added | 71.16 | ||
| CGEM | cullinan therapeutics inc | 0.56 | 1,176,170 | 19,689,100 | added | 567 | ||
| CNMD | conmed corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CSTL | castle biosciences inc | 0.27 | 331,986 | 9,468,240 | reduced | -20.21 | ||
| CUTR | cutera inc | 0.14 | 29,000,000 | 4,976,410 | unchanged | 0.00 | ||
| CUTR | cutera inc | 0.11 | 25,240,000 | 4,038,410 | unchanged | 0.00 | ||
| DAWN | day one biopharmaceuticals i | 1.92 | 4,873,850 | 67,892,800 | added | 60.54 | ||